The revised response criteria for malignant lymphoma incorporated FDG PET for determination of response.
Chief of the Lymphoma Service Andrew Zelenetz discusses a retrospective review performed to understand the frequency of FDG avidity across a range of lymphoma histologies and to compare diagnostic yield to CT. Diagnostic utility of bone marrow biopsy was also evaluated.
